Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study.

Francesco UrsiniEmilio RussoDaniele MauroLudovico AbenavoliGiorgio AmmerataAlfonso SerraoRosa Daniela GrembialeGiovambattista De SarroIgnazio OlivieriSalvatore D'angelo

Published in: European journal of clinical investigation (2017)

Our results provide preliminary evidence for a potential role of complement C3 as a surrogate biomarker of NAFLD in RA patients.

Keyphrases

rheumatoid arthritis patients
disease activity
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
prognostic factors
physical activity
systemic lupus erythematosus
risk factors
fatty acid